Dr. Marcus Iwane has completed his residency training in the JABSOM/Hawai`i Residency Programs, and is already “giving back” to the John A. Burns School of Medicine (JABSOM) by helping to oversee the instruction of new clinicans. Dr. Iwane was on hand during the week of June 27 at JABSOM, assisting third-year medical students in their “Transition to Clerkship” course in the SimTiki Center.
Click above, on YouTube, to watch a brief interview with Dr. Iwane about the on-hands training at SimTiki Center, JABSOM’s patient simulation center.
Also from 2010: Hitting home runs in radiology oncology
Since his graduation from JABSOM in 2010, Dr. Stephen G. Chun has gone from being a surgical intern with the Department of General Surgery at JABSOM (2010-2011) to a resident in Radiation Oncology in the Department of Radiation Oncology at the Simmons Comprehensive Cancer Center of the University of Texas Southwestern Medical Center. He expects to graduate in 2015.
During his residency, Stephen has focused on patient care and research. “In the near future, UT Southwestern plans open a Phase I clinical trial here I authored and am co-investigator on entitled – ‘A Phase I CyberKnife Accelerated Hemilarynx Stereotactic Radiosurgery Study for Early-stage Glottic Larynx Cancer’. It was recently approved by the department and Head and Neck DOT here at UT Southwestern”, writes Stephen. “We aim to shorten treatment times, improve cure rates, and improve toxicity for laryngeal cancer.”
Dr. Chun was one of only two Radiation Oncology residents in the country selected in 2013 for a RTOG/ACR (Radiation Therapy Oncology Group/American College of Radiology) Radiation Oncology Resident Training Fellowship. He will travel to Philadelphia in September for that learning opportunity.
Also, be on the lookout for a publication Stephen has authored that will appear in the Journal of Clinical Oncology in the near future that was accepted on April 23. The citation is: Chun SG, Iyengar P, Gerber DG, Hogan RN, Timmerman RD. Optic neuropathy and blindness associated with Crizotinib for Non-Small Cell Lung Cancer with EML4-ALK translocation. Journal of Clinical Oncology, in press.
Don’t forget to sign up on line for July 27’s “RECONNECT” MD Reunion Event! Go to ALUMNI EVENT to learn all about it.